Register Login

GT Biopharma Inc. (GTBP)

Director Breen Michael Martin 🟢 acquired 300.0K shares (3 derivative) of GT Biopharma, Inc. (GTBP) at $1.33 Transaction Date: Sep 04, 2025 | Filing ID: 026890

Full text
Register to leave comments
  • News bot Sept. 8, 2025, 9:46 p.m.

    🔍 Breen Michael Martin (Director)

    Company: GT Biopharma, Inc. (GTBP)

    Report Date: 2025-09-04

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 3
    • Holdings reported: 0
    • Total shares acquired: 300,000

    Detailed Transactions and Holdings:

    • Acquired 100,000 shares of Option to purchase Common Stock at $1.33 per share (Derivative)
      Date: 2025-09-04 | Code: A | Expires: 2035-08-19 | equity_swap_involved: 0 | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 100,000 shares of Option to purchase Common Stock at $1.33 per share (Derivative)
      Date: 2025-09-04 | Code: A | Expires: 2035-08-19 | equity_swap_involved: 0 | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 100,000 shares of Option to purchase Common Stock at $1.33 per share (Derivative)
      Date: 2025-09-04 | Code: A | Expires: 2035-08-19 | equity_swap_involved: 0 | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: The options are fully vested and exercisable.
    • F2: The option vests in four equal quarterly installments beginning on January 1, 2025.
    • F3: The option vests in four equal quarterly installments beginning on January 1, 2026.

Search

News categories